MAEIX
Price
$66.54
Change
-$2.02 (-2.95%)
Updated
Dec 18 closing price
VFINX
Price
$543.37
Change
-$16.51 (-2.95%)
Updated
Dec 18 closing price
Ad is loading...

MAEIX vs VFINX

Header iconMAEIX vs VFINX Comparison
Open Charts MAEIX vs VFINXBanner chart's image
MoA Equity Index Fund
Price$66.54
Change-$2.02 (-2.95%)
VolumeN/A
CapitalizationN/A
Vanguard 500 Index Investor
Price$543.37
Change-$16.51 (-2.95%)
VolumeN/A
CapitalizationN/A
MAEIX vs VFINX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MAEIX vs. VFINX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MAEIX is a StrongBuy and VFINX is a StrongBuy.

FUNDAMENTALS
Fundamentals
VFINX has more cash in the bank: 1.37T vs. MAEIX (6B). MAEIX (1.27) and VFINX (1.24) have matching dividends . MAEIX was incepted earlier than VFINX: MAEIX (32 years) vs VFINX (48 years). MAEIX is a more actively managed with annual turnover of: 4.07 vs. VFINX (2.00). VFINX has a lower initial minimum investment than MAEIX: VFINX (0) vs MAEIX (3000). VFINX annual gain was more profitable for investors over the last year : 27.63 vs. MAEIX (19.87). VFINX return over 5 years is better than : 88.65 vs. MAEIX (57.42).
MAEIXVFINXMAEIX / VFINX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence32 years48 years-
Gain YTD19.08427.27570%
Front LoadN/AN/A-
Min. Initial Investment30000-
Min. Initial Investment IRAN/AN/A-
Net Assets6B1.37T0%
Annual Yield % from dividends1.271.24102%
Returns for 1 year19.8727.6372%
Returns for 3 years18.2330.9959%
Returns for 5 years57.4288.6565%
Returns for 10 years136.65193.6271%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LX6.090.31
+5.36%
LexinFintech Holdings Ltd
DDOG156.911.09
+0.70%
Datadog
PAR78.060.08
+0.10%
PAR Technology Corp
HRI195.00-4.00
-2.01%
Herc Holdings
BRNS0.92-0.05
-5.26%
Barinthus Biotherapeutics plc